Cingulate (CING) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $4.39, -3.94% vs the prior close of $4.57.
- Volume 175.80K shares, 1.5x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CING slides 3.9% to $4.39, a 3-month low, 4 down days in a row. Closed at $4.39, -3.94% vs the prior close of $4.57. Day range $4.28–$4.57, opened at $4.55.
CING daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — CING slides 3.9% to $4.39, a 3-month low, 4 down days in a row
- Closed at $4.39, -3.94% vs the prior close of $4.57. Day range $4.28–$4.57, opened at $4.55.
- Volume was 175.80K shares, 1.5x its 50-day average of 114.52K.
- Price is -13.8% vs its 50-day average ($5.09) and -19.2% vs its 200-day average ($5.43).
- 52-week range $3.16–$11.89; today's close sits at 14% of that range, 63.1% below the 52-week high.
- That makes 4 straight losses.
Oct 14, 2026 — CING slides 3.2% to $4.57, a 1-month low, 3 down days in a row
- Closed at $4.57, -3.18% vs the prior close of $4.72. Day range $4.56–$4.77, opened at $4.66.
- Volume was 105.30K shares, 0.9x its 50-day average of 117.09K.
- Price is -10.5% vs its 50-day average ($5.11) and -15.8% vs its 200-day average ($5.43).
- 52-week range $3.16–$11.89; today's close sits at 16% of that range, 61.6% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — CING dips 2.5% to $4.72, a 1-month low
- Closed at $4.72, -2.48% vs the prior close of $4.84. Day range $4.68–$4.94, opened at $4.85.
- Volume was 73.20K shares, 0.6x its 50-day average of 118.33K.
- Price is -7.7% vs its 50-day average ($5.11) and -13.0% vs its 200-day average ($5.43).
- 52-week range $3.16–$11.89; today's close sits at 18% of that range, 60.3% below the 52-week high.
Oct 12, 2026 — CING dips 1.0% to $4.84
- Closed at $4.84, -1.02% vs the prior close of $4.89. Day range $4.81–$4.89, opened at $4.81.
- Volume was 30.20K shares, 0.3x its 50-day average of 118.93K — lighter than usual.
- Price is -5.4% vs its 50-day average ($5.11) and -10.8% vs its 200-day average ($5.42).
- 52-week range $3.16–$11.89; today's close sits at 19% of that range, 59.3% below the 52-week high.
Oct 9, 2026 — CING ends flat (+0.2%) to $4.89
- Closed at $4.89, +0.20% vs the prior close of $4.88. Day range $4.77–$4.97, opened at $4.87.
- Volume was 27.80K shares, 0.2x its 50-day average of 120.87K — lighter than usual.
- Price is -4.4% vs its 50-day average ($5.11) and -9.8% vs its 200-day average ($5.42).
- 52-week range $3.16–$11.89; today's close sits at 20% of that range, 58.9% below the 52-week high.
Oct 8, 2026 — CING ends flat (+0.2%) to $4.88
- Closed at $4.88, +0.21% vs the prior close of $4.87. Day range $4.75–$4.98, opened at $4.84.
- Volume was 75.70K shares, 0.6x its 50-day average of 121.86K.
- Price is -4.5% vs its 50-day average ($5.11) and -9.9% vs its 200-day average ($5.42).
- 52-week range $3.16–$11.89; today's close sits at 20% of that range, 59.0% below the 52-week high.
Oct 7, 2026 — CING dips 0.4% to $4.87
- Closed at $4.87, -0.41% vs the prior close of $4.89. Day range $4.67–$4.96, opened at $4.82.
- Volume was 115.60K shares, 0.9x its 50-day average of 124.33K.
- Price is -4.6% vs its 50-day average ($5.10) and -10.0% vs its 200-day average ($5.41).
- 52-week range $3.16–$11.89; today's close sits at 20% of that range, 59.0% below the 52-week high.
Oct 6, 2026 — CING rises 2.9% to $4.89
- Closed at $4.89, +2.95% vs the prior close of $4.75. Day range $4.75–$5.00, opened at $4.75.
- Volume was 111.40K shares, 0.9x its 50-day average of 125.12K.
- Price is -4.1% vs its 50-day average ($5.10) and -9.6% vs its 200-day average ($5.41).
- 52-week range $3.16–$11.89; today's close sits at 20% of that range, 58.9% below the 52-week high.
Oct 5, 2026 — CING ends flat (-0.2%) to $4.75
- Closed at $4.75, -0.21% vs the prior close of $4.76. Day range $4.63–$4.91, opened at $4.82.
- Volume was 139.80K shares, 1.1x its 50-day average of 123.88K.
- Price is -6.7% vs its 50-day average ($5.09) and -12.1% vs its 200-day average ($5.40).
- 52-week range $3.16–$11.89; today's close sits at 18% of that range, 60.1% below the 52-week high.
Oct 2, 2026 — CING ends flat (+0.2%) to $4.76
- Closed at $4.76, +0.21% vs the prior close of $4.75. Day range $4.70–$4.90, opened at $4.79.
- Volume was 52.10K shares, 0.4x its 50-day average of 124.99K — lighter than usual.
- Price is -6.4% vs its 50-day average ($5.09) and -11.8% vs its 200-day average ($5.40).
- 52-week range $3.16–$11.89; today's close sits at 18% of that range, 60.0% below the 52-week high.
- SEC filings that day: 8-K.
CING latest news & SEC filings
Every SEC filing by or about CING in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$5.87M (prior year -$4.98M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.45 (prior year -$1.14) (loss narrowed vs Jun 30, 2025)
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jul 20, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 20, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 20, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 20, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 20, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 15, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Jul 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 5.07 — Reported shareholder vote results.
Jul 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade CING
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 14, 2026, Mar 18, 2026, Nov 13, 2025. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.73% (largest 4.5%).
- Liquidity: about 92.28K shares (≈$405.09K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $4.39 vs a range of $3.16–$11.89 (14% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 5 open-market buys, 0 sales; latest: Thomas Jeffrey Hargroves bought 97,276 shares on Feb 13, 2026.
- Latest filings: 8-K Oct 2, 2026; 10-Q Aug 13, 2026; 8-K Aug 13, 2026.
- Share count: 14.54M shares outstanding (Aug 12, 2026), +168.7% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
CING market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 4.55 | 4.57 | 4.28 | 4.39 | 175.80K |
| Oct 14, 2026 | 4.66 | 4.77 | 4.56 | 4.57 | 105.30K |
| Oct 13, 2026 | 4.85 | 4.94 | 4.68 | 4.72 | 73.20K |
| Oct 12, 2026 | 4.81 | 4.89 | 4.81 | 4.84 | 30.20K |
| Oct 9, 2026 | 4.87 | 4.97 | 4.77 | 4.89 | 27.80K |
| Oct 8, 2026 | 4.84 | 4.98 | 4.75 | 4.88 | 75.70K |
| Oct 7, 2026 | 4.82 | 4.96 | 4.67 | 4.87 | 115.60K |
| Oct 6, 2026 | 4.75 | 5.00 | 4.75 | 4.89 | 111.40K |
| Oct 5, 2026 | 4.82 | 4.91 | 4.63 | 4.75 | 139.80K |
| Oct 2, 2026 | 4.79 | 4.90 | 4.70 | 4.76 | 52.10K |
| Oct 1, 2026 | 4.95 | 4.95 | 4.74 | 4.75 | 48.80K |
| Sep 30, 2026 | 4.91 | 5.02 | 4.82 | 4.95 | 66.30K |
| Sep 29, 2026 | 4.88 | 4.97 | 4.84 | 4.91 | 66.60K |
| Sep 28, 2026 | 4.97 | 4.97 | 4.59 | 4.82 | 171.90K |
| Sep 25, 2026 | 5.01 | 5.12 | 4.80 | 4.83 | 147.50K |
| Sep 24, 2026 | 5.01 | 5.07 | 4.81 | 5.06 | 82.50K |
| Sep 23, 2026 | 5.10 | 5.22 | 4.93 | 4.98 | 118.20K |
| Sep 22, 2026 | 5.26 | 5.35 | 5.12 | 5.14 | 78.10K |
| Sep 21, 2026 | 5.27 | 5.48 | 5.21 | 5.23 | 75.50K |
| Sep 18, 2026 | 5.11 | 5.28 | 5.09 | 5.24 | 83.20K |
About Cingulate
Cingulate (CING) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in KANSAS CITY, KS. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1862150.
CING board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Thomas Jeffrey Hargroves | Director | Jul 20, 2026 |
| Bryan Jay Lawrence | Director | Jul 20, 2026 |
| Shane J. Schaffer | Chief Executive Officer | Jul 20, 2026 |
| Peter J. Werth | Director | Jul 20, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Matthew Brams | EVP and Chief Medical Officer | Jul 20, 2026 |
| Jennifer L. Callahan | EVP and CFO | Jul 20, 2026 |
| Bryan Wade Downey | EVP & Chief Commercial Officer | Jul 20, 2026 |
| Nilay Dahyabhai Patel | EVP, CLO and CCO | Mar 11, 2026 |
| Shane J. Schaffer | Chief Executive Officer | Jul 20, 2026 |
| Raul R. Silva | EVP and CSO | Jul 20, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Feb 13, 2026 | Thomas Jeffrey Hargroves | Buy | 97,276 | $5.04 |
| Feb 6, 2026 | Peter J. Werth | Buy | 19,455 | $5.04 |
| Feb 6, 2026 | Jennifer L. Callahan | Buy | 4,864 | $5.04 |
| Feb 6, 2026 | Shane J. Schaffer | Buy | 6,809 | $5.04 |
| Feb 6, 2026 | Matthew Brams | Buy | 1,946 | $5.04 |
CING financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-22.45M | -4.44 | $-17.25M |
| Dec 31, 2024 | — | $-16.56M | -10.86 | $-18.45M |
| Dec 31, 2023 | — | $-23.53M | -311.99 | $-15.03M |
| Dec 31, 2022 | — | $-17.68M | -29.35 | $-15.88M |
| Dec 31, 2021 | — | $-20.71M | — | $-10.43M |
Latest balance sheet: total assets $33.07M, total liabilities $9.60M, cash $28.40M (as of Jun 30, 2026).
CING earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $4.99 |
| May 14, 2026 | 8-K Item 2.02 (results) | $4.39 |
| Mar 18, 2026 | 8-K Item 2.02 (results) | $8.04 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $3.33 |
| Aug 19, 2025 | 8-K Item 2.02 (results) | $3.76 |
| May 8, 2025 | 8-K Item 2.02 (results) | $4.09 |
| Mar 26, 2025 | 8-K Item 2.02 (results) | $4.14 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $3.44 |
| Aug 13, 2024 | 8-K Item 2.02 (results) | — |
| May 8, 2024 | 8-K Item 2.02 (results) | — |
| Apr 1, 2024 | 8-K Item 2.02 (results) | — |
| Nov 13, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on CING
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.